Table 3.
Statistics of all the curated AI-solvable clinical trial datasets.
| Tasks | # trials (I/II/III/IV) | # drugs | # med device | # other inter | # diseases | Intervention study (%) |
|---|---|---|---|---|---|---|
| trial duration forecasting | 143.8K (13.5K/13.4K/9.2K/7.1K) | 40.8K | 21.1K | 83.6K | 44.6K | 77.3% |
| patient dropout event forecasting | 62.1K (4.2K/15.8K/11.5K/6.9K) | 29.7K | 10.9K | 20.7K | 21.9K | 94.5% |
| serious adverse event forecasting | 31.3K (2.0K/8.1K/4.8K/2.9K) | 15.9K | 6.6K | 12.4K | 15.9K | 96.0% |
| mortality event prediction | 31.3K (2.0K/8.1K/4.8K/2.9K) | 15.9K | 6.6K | 12.4K | 15.9K | 96.0% |
| trial approval forecasting | 43.2K (4.5K/12.5K/9.2K/4.5K) | 24.1K | 3.3K | 12.6K | 19.5K | 93.0% |
| trial failure reason identification | 41.4K (4.3K/8.8K/4.2K/3.5K) | 17.7K | 6.6K | 16.9K | 21.9K | 86.8% |
| eligibility criteria design | 136.4K (19.4K/14.2K/10.8K/10.6K) | 48.5K | 16.2K | 75.0K | 36.6K | 84.9% |
| drug dose finding | 12.8K (0/12.8K/0/0) | 11.0K | 0.1K | 1.2K | 7.3K | 100% |